Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nechama Kalter

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmaceutics|May 27, 2023
Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood DisordersDaniel Allen, Nechama Kalter, Michael Rosenberg, et al.
Nucleic Acids Research|July 30, 2024
Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0Guy Assa, Nechama Kalter, Michael Rosenberg, et al.
Molecular Therapy. Methods & Clinical Development|April 14, 2025
Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencingNechama Kalter, Saurabh Gulati, Michael Rosenberg, et al.
Nature Communications|October 27, 2023
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applicationsDaniel Allen, Orli Knop, Bryan Itkowitz, et al.
Molecular Therapy. Nucleic Acids|August 8, 2025
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challengesNechama Kalter, Carla Fuster-García, Alfredo Silva, et al.
Molecular Therapy. Nucleic Acids|May 25, 2026
Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCsOrli Knop, Nimrod Ben Haim, Nechama Kalter, et al.
Frontiers in Genome Editing|November 19, 2025
Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113)María Ortiz-Bueno, Iris Ramos-Hernández, Luis Algeciras-Jiménez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaAlexis Talbot, Ke Li, Jae Hyun J Lee, et al.
Molecular Therapy. Nucleic Acids|November 30, 2023
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDiAlessia Cavazza, Ayal Hendel, Rasmus O Bak, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmaceutics|May 27, 2023
Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood DisordersDaniel Allen, Nechama Kalter, Michael Rosenberg, et al.
Nucleic Acids Research|July 30, 2024
Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0Guy Assa, Nechama Kalter, Michael Rosenberg, et al.
Molecular Therapy. Methods & Clinical Development|April 14, 2025
Precise measurement of CRISPR genome editing outcomes through single-cell DNA sequencingNechama Kalter, Saurabh Gulati, Michael Rosenberg, et al.
Nature Communications|October 27, 2023
CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applicationsDaniel Allen, Orli Knop, Bryan Itkowitz, et al.
Molecular Therapy. Nucleic Acids|August 8, 2025
Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challengesNechama Kalter, Carla Fuster-García, Alfredo Silva, et al.
Molecular Therapy. Nucleic Acids|May 25, 2026
Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCsOrli Knop, Nimrod Ben Haim, Nechama Kalter, et al.
Frontiers in Genome Editing|November 19, 2025
Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113)María Ortiz-Bueno, Iris Ramos-Hernández, Luis Algeciras-Jiménez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Gene-corrected regulatory T cell therapy for IL2RA deficiencyAlvin S Ha, Nechama Kalter, Michael Rosenberg, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple MyelomaAlexis Talbot, Ke Li, Jae Hyun J Lee, et al.
Molecular Therapy. Nucleic Acids|November 30, 2023
Progress and harmonization of gene editing to treat human diseases: Proceeding of COST Action CA21113 GenE-HumDiAlessia Cavazza, Ayal Hendel, Rasmus O Bak, et al.
Pageof 1